Assembly Bio to receive approximately $20.1 million equity investment and $10 million in accelerated funding under the collaboration, extending cash runway to mid-2026— —Additional equity investment ...
Assembly Biosciences shares were up 19% at $16.01 after receiving an equity investment and accelerated funding from Gilead Sciences. Shares of the biotechnology company hit a 52-week high of $19.93 on ...
Assembly Biosciences said it has received a $20.1 million equity investment from Gilead Sciences, along with $10 million in accelerated funding. Gilead is buying the additional Assembly Bio stock, ...
Dec. 19, 2024 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative antiviral therapeutics targeting serious viral diseases, today announced ...
Assembly Biosciences (ASMB) announced an equity investment of $20.1M by Gilead Sciences (GILD) to purchase additional Assembly Bio common stock and an amendment to their collaboration to advance the ...
Assembly Biosciences said it has received a $20.1 million equity investment from Gilead Sciences, along with $10 million in accelerated funding. Gilead is buying the additional Assembly Bio stock ...
Seeking Alpha on MSN4d
Gilead raises Assembly Bio stake to ~30%Shares of Assembly Biosciences (NASDAQ:ASMB) traded higher on Thursday after Gilead Sciences (NASDAQ:GILD) agreed to increase ...
Assembly Biosciences, Inc. (NASDAQ:ASMB), a biopharmaceutical company currently trading at $13.51 and identified as undervalued by InvestingPro's Fair Value model, has entered into an amended ...
Assembly Biosciences, Inc. (NASDAQ:ASMB), a biopharmaceutical company currently trading at $13.51 and identified as undervalued by InvestingPro's Fair Value model, has entered into an amended ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback